Registry for psoriatic arthritis and spine arthritis patients starting treatment
Part of Bones, joints & muscles, Skin clinical trials.
This is a patient registry that tracks people with psoriatic arthritis or spine inflammatory arthritis when they start a specific new treatment. It helps researchers learn about real-world outcomes and safety as patients receive care over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have psoriatic arthritis or a spine inflammatory arthritis diagnosis (axial spondyloarthritis or ankylosing spondylitis)
- Be starting an eligible medication for your condition at the time you join (either beginning or newly prescribed)
- Not have rheumatoid arthritis, lupus, or another autoimmune inflammatory arthritis
- Not be in an interventional drug clinical trial at the same time (you can join observational registries instead)
- Be able and willing to sign written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry is collecting information about people with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis who are starting or needing biologic or targeted medicines. It may help researchers better understand how these treatments work in real life.
This study follows people who were recently diagnosed with spondyloarthritis (a type of arthritis) to see how their symptoms change over time. It helps doctors understand the early stages of the disease better.
This study is a psoriasis registry that records real-world information about people starting a systemic (whole-body) treatment for the first time. It helps doctors understand how these treatments work in everyday care and may improve future treatment decisions.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study looks at how well advanced treatments work for people with psoriatic arthritis, and whether results differ for sex and gender. You may be eligible if your psoriatic arthritis is active and you are planning to start an advanced treatment for symptoms in the joints and surrounding areas.
This trial is for people with rheumatoid arthritis or spondyloarthritis who haven't responded well to standard treatments. It aims to study and improve care for those needing advanced biologic or synthetic therapies.
Hear when a new Psoriatic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.